No | Areas of KAP regarding FH being tested | Total (n = 170) | Male (n = 83) | Female (n = 87) | P value |
---|---|---|---|---|---|
Awareness items | |||||
1 | Familiar with FH | 92 (54.10%) | 41 (49.40%) | 51 (58.60%) | 0.146 |
2 | Aware of NICE Guideline on FH | 28 (16.50%) | 13 (15.70%) | 15 (17.20%) | 0.472 |
15 | Aware of lipid specialist clinic | 86 (50.60%) | 28 (33.70%) | 58 (66.70%) | 0.0001 |
19 | Aware of other international FH guidelines | ||||
Integrated Guidance on the Care of Familial Hypercholesterolaemia by the International FH Foundation (2014) | 16 (9.40%) | 12 (14.50%) | 4 (4.60%) | 0.025 | |
Homozygous Familial Hypercholesterolaemia: New Insight and Guidance for Clinicians to improve Detection and Clinical Management. A Position Paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society (EAS) (2014) | 26 (15.30%) | 21 (25.30%) | 5 (5.70%) | 0.0001 | |
The Japanese Guidelines for the Management of Familial Hypercholesterolemia (Harada-Shiba, 2012) | 10 (5.90%) | 9 (10.80%) | 1 (1.10%) | 0.007 | |
Clinical Guidance by the National Lipid Association (NLA) Expert Panel on Familial Hypercholesterolaemia (2011) | 11 (6.50%) | 10 (12.00%) | 1 (1.10%) | 0.004 | |
Others | 0 (0.00%) | 0 (0.00%) | 0 (0.00%) | 1.000 | |
20 | Aware of FH diagnostic criteria | ||||
Dutch Lipid Clinic Network Criteria | 22 (12.90%) | 17 (20.50%) | 5 (5.70%) | 0.004 | |
Simon Broome Register Criteria | 12 (7.10%) | 11 (13.30%) | 1 (1.10%) | 0.002 | |
US MED-PED Criteria | 11 (6.50%) | 8 (9.80%) | 3 (3.40%) | 0.091 | |
Japanese Criteria | 8 (4.70%) | 7 (8.40%) | 1 (1.10%) | 0.027 | |
Others | 0 (0.00%) | 0 (0.00%) | 0 (0.00%) | 1.000 | |
Overall awareness of FH (total score 13) | 1.89 ± 1.63 (0.00–6.00) | 2.13 ± 1.52 (0.00–6.00) | 1.67 ± 1.16 (0.00–6.00) | 0.068 | |
Poor awareness (< 7.5) | 170 (100.00%) | 83 (100.00%) | 87 (100.00%) | 1.000 |